Skip to main navigation
Skip to search
Skip to main content
VTT's Research Information Portal Home
Home
Profiles
Research output
Projects
Datasets
Research units
Research Infrastructures
Activities
Prizes
Press/Media
Impacts
Search by expertise, name or affiliation
Pharmacokinetic aspects of retinal drug delivery
Eva M. del Amo
, Anna Kaisa Rimpelä
, Emma Heikkinen
, Otto K. Kari
, Eva Ramsay
, Tatu Lajunen
, Mechthild Schmitt
, Laura Pelkonen
, Madhushree Bhattacharya
, Dominique Richardson
, Astrid Subrizi
, Tiina Turunen
, Mika Reinisalo
, Jaakko Itkonen
, Elisa Toropainen
,
Marco Casteleijn
, Heidi Kidron
, Maxim Antopolsky
, Kati Sisko Vellonen
, Marika Ruponen
Arto Urtti
*
Show 1 more
Show less
*
Corresponding author for this work
Not published at VTT
University of Eastern Finland
University of Helsinki
Research output
:
Contribution to journal
›
Review Article
›
peer-review
586
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacokinetic aspects of retinal drug delivery'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacokinetics
100%
Retinal Drug Delivery
100%
Retina
75%
Drug Delivery
50%
Posterior Eye Segment
50%
Targeted Delivery
25%
Blindness
25%
Tolerability
25%
Impaired Vision
25%
Delivery System
25%
Pharmacodynamics
25%
Route of Administration
25%
Soluble Receptor
25%
Drug Delivery Technology
25%
Drug System
25%
Ophthalmology
25%
Intravitreal Injection
25%
Subretinal
25%
Intravitreal Drugs
25%
Routing System
25%
Drug Administration Routes
25%
Drug Action
25%
Periocular
25%
Anti-VEGF Antibody
25%
Ocular Drug Delivery
25%
Choice Method
25%
Suprachoroidal
25%
INIS
drug delivery
100%
drugs
71%
reviews
42%
retina
42%
delivery
28%
eyes
28%
administration
28%
safety
14%
data
14%
diseases
14%
doses
14%
laboratories
14%
antibodies
14%
injection
14%
vision
14%
receptors
14%
choroid
14%
ophthalmology
14%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Tolerability
25%
Pharmacodynamics
25%
Ocular Drug
25%
Drug Administration
25%
Receptor
25%
Vasculotropin Antibody
25%
Visual Impairment
25%
Intravitreal Administration
25%
Drug Action
25%
Diseases
25%